390 related articles for article (PubMed ID: 19276540)
1. A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease.
Lovell MA
J Alzheimers Dis; 2009; 16(3):471-83. PubMed ID: 19276540
[TBL] [Abstract][Full Text] [Related]
2. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
Lovell MA; Smith JL; Xiong S; Markesbery WR
Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263
[TBL] [Abstract][Full Text] [Related]
3. A potential role for zinc alterations in the pathogenesis of Alzheimer's disease.
Lyubartseva G; Lovell MA
Biofactors; 2012; 38(2):98-106. PubMed ID: 22447723
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
Smith JL; Xiong S; Markesbery WR; Lovell MA
Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
[TBL] [Abstract][Full Text] [Related]
5. Elevated zinc transporter-6 in mild cognitive impairment, Alzheimer disease, and pick disease.
Lovell MA; Smith JL; Markesbery WR
J Neuropathol Exp Neurol; 2006 May; 65(5):489-98. PubMed ID: 16772872
[TBL] [Abstract][Full Text] [Related]
6. Disruption of zinc homeostasis and the pathogenesis of senile dementia.
Kawahara M; Mizuno D; Koyama H; Konoha K; Ohkawara S; Sadakane Y
Metallomics; 2014 Feb; 6(2):209-19. PubMed ID: 24247360
[TBL] [Abstract][Full Text] [Related]
7. Zinc and Alzheimer's disease: is there a direct link?
Cuajungco MP; Lees GJ
Brain Res Brain Res Rev; 1997 Apr; 23(3):219-36. PubMed ID: 9164672
[TBL] [Abstract][Full Text] [Related]
8. Screening a specific Zn(ii)-binding peptide for improving the cognitive decline of Alzheimer's disease in APP/PS1 transgenic mice by inhibiting Zn
Zhang X; Zhong M; Zhao P; Zhang X; Li Y; Wang X; Sun J; Lan W; Sun H; Wang Z; Gao H
Biomater Sci; 2019 Nov; 7(12):5197-5210. PubMed ID: 31588929
[TBL] [Abstract][Full Text] [Related]
9. Zinc and its effects on oxidative stress in Alzheimer's disease.
Yuan Y; Niu F; Liu Y; Lu N
Neurol Sci; 2014 Jun; 35(6):923-8. PubMed ID: 24522515
[TBL] [Abstract][Full Text] [Related]
10. Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain.
Lyubartseva G; Smith JL; Markesbery WR; Lovell MA
Brain Pathol; 2010 Mar; 20(2):343-50. PubMed ID: 19371353
[TBL] [Abstract][Full Text] [Related]
11. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
[TBL] [Abstract][Full Text] [Related]
12. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.
Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY
Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746
[TBL] [Abstract][Full Text] [Related]
13. A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy.
Khan MZ
Biomed Pharmacother; 2016 Apr; 79():263-72. PubMed ID: 27044837
[TBL] [Abstract][Full Text] [Related]
14. The Rapid Exchange of Zinc(2+) Enables Trace Levels to Profoundly Influence Amyloid-β Misfolding and Dominates Assembly Outcomes in Cu(2+)/Zn(2+) Mixtures.
Matheou CJ; Younan ND; Viles JH
J Mol Biol; 2016 Jul; 428(14):2832-46. PubMed ID: 27320389
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional roles of zinc in Alzheimer's disease.
Xie Z; Wu H; Zhao J
Neurotoxicology; 2020 Sep; 80():112-123. PubMed ID: 32717200
[TBL] [Abstract][Full Text] [Related]
16. [The role of zinc ions and structural polymorphism of β-amyloid in the Alzheimer's disease initiation].
Kulikova AA; Makarov AA; Kozin SA
Mol Biol (Mosk); 2015; 49(2):249-63. PubMed ID: 26065253
[TBL] [Abstract][Full Text] [Related]
17. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
Abelein A; Gräslund A; Danielsson J
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
[TBL] [Abstract][Full Text] [Related]
18. Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy.
Solovyev N; El-Khatib AH; Costas-Rodríguez M; Schwab K; Griffin E; Raab A; Platt B; Theuring F; Vogl J; Vanhaecke F
J Biol Chem; 2021; 296():100292. PubMed ID: 33453282
[TBL] [Abstract][Full Text] [Related]
19. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
[TBL] [Abstract][Full Text] [Related]
20. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
